Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

19.85
+1.357.30%
Post-market: 19.990.1400+0.71%19:50 EDT
Volume:1.89M
Turnover:37.06M
Market Cap:1.92B
PE:-3.40
High:19.94
Open:18.75
Low:18.70
Close:18.50
52wk High:42.37
52wk Low:18.29
Shares:96.48M
Float Shares:92.79M
Volume Ratio:0.67
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.03%
PB:-23.94
PE(LYR):-3.40

Loading ...

Ultragenyx Pharmaceutical Shares Halted, Pending Material News Release

MT Newswires Live
·
Dec 29, 2025

Ultragenyx Setrusumab Fails to Meet Primary Fracture Reduction Endpoint in Phase 3 Osteogenesis Imperfecta Trials

Reuters
·
Dec 29, 2025

Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (Ux143) in Osteogenesis Imperfecta

THOMSON REUTERS
·
Dec 29, 2025

Ultragenyx Pharmaceutical Inc - Studies Show Improvements in Bone Mineral Density

THOMSON REUTERS
·
Dec 29, 2025

Ultragenyx Pharmaceutical Inc - to Implement Significant Expense Reductions

THOMSON REUTERS
·
Dec 29, 2025

Ultragenyx Pharmaceutical Inc - Phase 3 Studies Fail to Meet Primary Endpoint

THOMSON REUTERS
·
Dec 29, 2025

12 Days of Christmas? 12 Stocks That Are Gifts for 2026

Dow Jones
·
Dec 25, 2025

Ultragenyx Grants 13,144 Restricted Stock Units to New Hires

Reuters
·
Dec 20, 2025

Ultragenyx CFO Howard Horn Reports Sale of Common Shares

Reuters
·
Dec 12, 2025

Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Analyst Commentary on Setrusumab Progress and Growth Outlook

Simply Wall St.
·
Nov 30, 2025

Ultragenyx Pharmaceutical to Participate in Upcoming Investor Conferences

Reuters
·
Nov 25, 2025

Ultragenyx Pharma Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 24, 2025

Ultragenyx price target lowered to $50 from $81 at Barclays

TIPRANKS
·
Nov 24, 2025

Ultragenyx Pharmaceutical Inc : Barclays Cuts Target Price to $50 From $81

THOMSON REUTERS
·
Nov 24, 2025

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Barclays

TIPRANKS
·
Nov 24, 2025

Ultragenyx Grants 18,180 Restricted Stock Units to New Hires Under Inducement Plan

Reuters
·
Nov 22, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 22, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Nov 21, 2025

J.P. Morgan Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Nov 21, 2025

U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology

Reuters
·
Nov 19, 2025